Dechra Pharmaceuticals PLC — Director's Dealing 2014

Nov 25, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9783X

Dechra Pharmaceuticals PLC

25 November 2014

25 November 2014

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company")

Director / PDMR Shareholding 

Dechra Pharmaceuticals PLC has been notified that, today, Ian Page (Chief Executive Officer) has transferred 250,000 ordinary shares in the Company to his spouse, Linda Page, for nil consideration.  

Following this transfer, Ian Page's, beneficial interest in the Company remains unchanged, being 955,701 shares, which represents 1.09% of the current issued share capital.

For further information, please contact:

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQKPDPPBDDPDB